Adagene Share Price

Adagene Share Price

NASDAQ: ADAG | Others
$1.75
-$0.27 (-13.15%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Adagene Stock Performance

Open
$2.00
Prev. Close
$2.02
Circuit Range
N/A
Day Range
$1.35 - $2.00
Year Range
$1.28 - $4.85
Volume
12,242
Average Traded
$1.70

Adagene Share Price Today

As of 22 November 2026, Adagene Inc.'s share price is $1.75. The stock opened at $2.00, compared to its previous close of $2.02. During today's trading session, Adagene Inc.'s share price traded between $1.35 and $2.00, with an average price of $1.68. Over the past 52 weeks, the stock has recorded a high of $4.85 and a low of $1.28. In terms of performance, Adagene Inc.'s share price has declined by 55.97% over the last six months and is down 15.46% on a year-on-year basis.

Adagene Share Price Chart

Line chart of the Adagene price trend over the selected period. The price fell overall, ranging from 1.38 to 2.01, ending at 1.75.
$1.35$2.00
L
Show Current Price
H

Adagene Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
N/A
EPS (TTM)
N/A
Revenue (TTM)
$7.67B
Return On Equity (TTM)
N/A
Profit Margin
-229.60%
Debt to Equity
N/A
Quarterly Earnings Growth YoY
N/A

Adagene Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$9.29$18.11$0.10$7.67
Net Profit-$79.97-$18.95-$33.42-$17.61
Net Profit Margin-860.82%-104.64%-33420.00%-229.60%
Income ChangeN/A76.30%-76.36%47.31%

Adagene Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets0.891.492.293.08
Current Assets77.3887.78113.44149.32
Total Assets78.2689.27115.73152.4
Non Current Liabilities1.190.5613.7114.23
Current Liabilities25.1738.1831.4655.08
Total Liabilities26.3638.7445.1769.31
Shareholders' Equity35.3550.5270.5683.09

Adagene Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-15.66-29.7-28.45-48.61
Investing0.481.11-0.08-0.69
Financing4.453.77-5.3717.82

About Adagene

Adagene Inc is a platform-driven, clinical-stage biotechnology company focused on the discovery and development of novel antibody-based cancer immunotherapies. The Company leverages computational biology to design and develop novel antibodies. Powered by its Dynamic Precision Library (DPL) platform, which fuels its NEObody, SAFEbody, and POWERbody technologies, it is developing a pipeline of immunotherapies. Its candidate, ADG126 (muzastotug), an anti-CTLA-4 SAFEbody, is in phase 1b/2 and phase 2 clinical development for metastatic microsatellite-stable colorectal cancer. Its clinical-stage products include ADG126 and ADG116, investigational fully human anti-CTLA-4 mAbs generated through SAFEbody and NEObody technologies.

Adagene Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$2.52
$1.78
-29.64%
Oct 2026
$3.09
$2.53
-21.06%
Sep 2026
$3.58
$3.21
-18.14%
Aug 2026
$3.69
$3.92
+4.54%
Jul 2026
$4.02
$3.75
-11.47%
Jun 2026
$3.80
$4.23
+6.42%
May 2026
$3.74
$3.98
+8.31%
Apr 2026
$4.13
$3.67
-9.16%
Mar 2026
$2.95
$4.04
+32.03%
Feb 2026
$2.70
$3.06
+10.47%
Jan 2026
$1.78
$2.77
+46.56%
Dec 2025
$2.07
$1.89
-8.70%

Adagene Share Price FAQs